Rotavirus gastroenteritis in Uzbekistan: Implications for vaccine policy in central Asia

Journal of Infectious Diseases

Volumn 200, Issue SUPPL. 1, 2009, Pages

  Flem, Elmira T ^a   Musabaev, Erkin ^b   Juraev, Rivojiddin ^b   Kerin, Tara ^c   Gentsch, Jon ^c   Glass, Roger I ^d   Bresee, Joseph S ^c  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b Institute of Virology   (Uzbekistan)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE;

ACUTE GASTROENTERITIS; ARTICLE; CAUSE OF DEATH; CHILD; CHILD HOSPITALIZATION; CLINICAL TRIAL; DISEASE SURVEILLANCE; FECES ANALYSIS; FEMALE; GENOTYPE; HEALTH CARE POLICY; HEALTH SURVEY; HUMAN; INFANT; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTICENTER STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; ROTAVIRUS; SCREENING TEST; UZBEKISTAN; VACCINATION; VIRUS DETECTION; VIRUS INFECTION; VIRUS STRAIN;

CHILD, PRESCHOOL; COST OF ILLNESS; GASTROENTERITIS; HOSPITALIZATION; HUMANS; IMMUNIZATION PROGRAMS; INFANT; INFANT, NEWBORN; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; UZBEKISTAN;

EID: 72849107340     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/605032     Document Type: Article

References (24)

1. World Health Organization. Rotavirus vaccines. Wkly Epidemiol Rec 2007; 82:285-295
2. American Academy of Pediatrics Committee on Infectious Diseases. Prevention of rotavirus disease: guidelines for use of rotavirus vaccine. Pediatrics 2007; 119:171-182
3. Vesikari T, Giaquinto C, Huppertz HI. Clinical trials of rotavirus vaccines in Europe. Pediatr Infect Dis J 2006; 25(Suppl 1):S42-7.
4. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354:11-22. (Pubitemid 43048947) (Pubitemid 43048947)
5. Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354:23-33. (Pubitemid 43048948) (Pubitemid 43048948)
6. Parashar UD, Gibson CJ, Bresse JS, Glass RI. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006; 12:304-306
7. Parashar UD, Bresee JS, Glass RI. The global burden of diarrhoeal disease in children. Bull World Health Organ 2003; 81:236. (Pubitemid 36542138)
8. UNICEF. 2007 Vaccine projections: quantities and pricing. UNICEF Supply Division, 2007. Available at: http://www.unicef.org/supply/index-7991.html. Accessed 22 February 2008.
9. Lob-Levyt J. Re: 2007 update on support to countries from the GAVI Alliance. Document GAVI/07/040/ir/hb. Geneva: GAVI Alliance, March 2007. Available at: http://www.gavialliance.org/resources/GAVI-Letter-Update-Mar07. pdf. Accessed 22 February 2008.
10. UNICEF. The state of the worlds children 2008. UNICEF, 2008. Available at: http://www.unicef.org/sowc08/statistics/tables.php. Accessed22 February 2008.
11. World Health Organization. WHO statistical information system (WHOSIS). Geneva: World Health Organization, 2000. Available at: http://www.who.int/ whosis/en/. Accessed 1 February 2008.
12. World Health Organization. WHO-UNICEF estimates of DTP3 coverage. Geneva: World Health Organization, 2007. Available at: http://www.who.int/immunization- monitoring/en/globalsummary/timeseries/tswucoveragedtp3.htm. Accessed 22 February 2008.
13. Centers for Disease Control and Prevention. Rotavirus surveillance news. Atlanta, GA: Centers for Disease Control and Prevention,March 2007. Available at: http://www.cdc.gov/rotavirus/newsletters/RV-Surveillance-News-March-2007. pdf. Accessed 22 February 2008.
14. Isakbaeva ET, Musabaev E, Antil L, et al. Rotavirus disease in Uzbekistan: cost-effectiveness of a new vaccine. Vaccine 2007; 25:373-380 (Pubitemid 44856079) (Pubitemid 44856079)
15. World Health Organization. Generic protocols for (i) hospital-based surveillance to estimate the burden of rotavirus gastroenteritis in children and (ii) a community-based survey on utilization of health care services for gastroenteritis in children. Field test version. Geneva:World Health Organization, 2002. Available at: http://www.who.int/vaccines-documents/ DocsPDF02/www698.pdf. Accessed 22 February 2008.
16. Banerjee I, Ramani S, Primrose B, et al. Modification of rotavirus multiplex RT-PCR for the detection of G12 strains based on characterization of emerging G12 rotavirus strains from South India. J Med Virol 2007; 79:1413-1421
17. Iturriza-Gómara M, Green J, Brown DW, Desselberger U, Gray JJ. Diversity within the VP4 gene of rotavirus P[8] strains: implications for reverse transcription-PCR genotyping. J Clin Microbiol 2000; 38: 898-901.
18. Iturriza-Gómara M, Kang G, Mammen A, et al. Characterization of G10P[11] rotaviruses causing acute gastroenteritis in neonates and infants in Vellore, India. J Clin Microbiol 2004; 42:2541-2547
19. Gouvea V, Glass RI, Woods P, et al. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol 1990; 28:276-282 (Pubitemid 20050935)
20. Gentsch JR, Glass RI,Woods P, et al. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol 1992; 30: 1365-1373
21. World Health Organization. Estimated rotavirus deaths for childrenunder 5 years of age: 2004, 527 000. Geneva: World Health Organization, 2006. Available at: http://www.who.int/immunization-monitoring/burden/rotavirus-estimates/en. Accessed 22 February 2008.
22. Bresee JS, Glass RI, Ivanoff B, Gentsch JR. Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries. Vaccine 1999; 17:2207-2222 (Pubitemid 29225672) (Pubitemid 29225672)
23. Gentsch JR, Woods PA, Ramachandran M, et al. Review of G and P typing results from a global collection of rotavirus strains: implications for vaccine development. J Infect Dis 1996; 174(Suppl 1):S30-6.
24. Santos N, Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 2005; 15:29-56. (Pubitemid 40070041)